Immunosuppressive treatment vs placebo/no treatment/non‐immunosuppressive supportive treatment
Death at final · primary membranous nephropathy in adults with nephrotic syndrome
Immunosuppressive treatment showed no clear difference in death at final compared with placebo/no treatment/non‐immunosuppressive supportive treatment (moderate certainty).
1 finding from 1 review
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome 2021 · Cochrane Headline outcomes onlyRR 0.73 [0.34, 1.59]16 studies · 944 participantsModerate